Overview

Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients

Status:
Completed
Trial end date:
2018-03-23
Target enrollment:
Participant gender:
Summary
This study is intended to investigate the pharmacodynamic drug-drug interaction as well as the safety and tolerability of isosorbite mononitrate and vericiguat in patients with stable coronary artery disease.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Collaborator:
Merck Sharp & Dohme Corp.